US 12,083,153 B1
الصحة - Health
2024
مكتب البراءات الأمريكي - US Patent Office
Ali; Enas M. (Hofouf, SA), Abdallah; Basem M. (Hofouf, SA)
A silver nanoparticle composition for controlling or inhibiting the growth of P. jirovecii can include biosynthesized silver nanoparticles and an extract of Farsetia aegyptiaca (FA). The biosynthesized silver nanoparticles can be Farsetia aegyptiaca silver nanoparticles (Fa-AgNPs) prepared using an extract of Farsetia aegyptiaca (FA). In an embodiment, the Farsetia aegyptiaca silver nanoparticles (Fa-AgNPs) can have particle sizes ranging from about 10 nm to about 35 nm.